Cutting-edge biomedical research and discovery is happening on Fairfield’s campus, fueled by professors deeply committed to involving students in meaningful research. Someday, one of those students just may make a discovery that could impact your life.
Unlike larger universities, where graduate students often dominate the research opportunities, “We have only undergraduates working with us in our research labs, and we are committed to mentoring them and giving them the necessary research training that they can’t get from taking a course,” said Shelley Phelan, PhD, professor of biology.
Dr. Phelan’s research centers on the regulation and function of genes in cancer cell biology. Currently, her work revolves around the use of natural plant compounds as anti-cancer agents, with a focus on breast cancer.
In her lab, students begin by reading the current literature, coming up with research questions, and developing hypotheses. That’s in addition to learning the technical skills needed to culture human cells, including learning how to maintain a sterile environment. And while that training can take eight to 10 hours a week, “it gives our students a real opportunity to stand out in their postgraduation pursuits. After all, the vast majority of them go on to medical school, other pre-health programs, or graduate programs in the sciences. They often land where they land because of the hours of training and mentorship they’ve had in our labs.”
Femi Gbayisomore ’22 can attest to that; he worked for a year and a half in Dr. Phelan’s lab, which led to a poster presentation at the American Association for Cancer Research conference with his lab partner and the co-authorship of a paper in a peer-reviewed journal.
“My decision to do research with Dr. Phelan was one of the better investments I’ve made in myself,” he said, crediting that experience with his acceptance to medical school.
As in Dr. Phelan’s lab, students working with assistant professor of biology Paul Riccio, PhD, also need to master aseptic mammalian cell culture to keep cells free of contamination, but that’s where his research diverges from Dr. Phelan’s.
“I’m interested in how organs recover from tissue loss and regenerate new cells. To understand this, we must explore how the regulation of the cell cycle is inherently different across organs,” said Dr. Riccio. “In diabetes our immune system destroys insulin-producing beta cells. So how do we get a robust number of these to last through life?”
Answering that question could lead to new cell therapies for Type 1 diabetes.